My Fund

Loading your portfolio…

Checking your account and saved picks.

Choose a startup

Explore all 1429 companies in this selection. Research each company before making your pick.

Includes historical VC holdings. A listing does not confirm current ownership or startup stage.

VC tracking →

Showing 1–8 of 8 startups

EON

Limited coverage

American Dynamism

RiseFinder summary

EON provides point-to-point data transfer through space using free-space laser optics and dedicated transfer capacity.

Andreessen Horowitz
endeavornetworks.com ↗
Research EON

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

EON provides point-to-point data transfer through space using free-space laser optics and dedicated transfer capacity.

Visit endeavornetworks.com ↗
Source category

American Dynamism

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

BIOVENTRIX, INC.

Limited coverage

Biotechnology

On its website, the company describes its work as “Revivent Therapy is an investigational cardiac remodeling technique performed by a cardiothoracic surgeon under general anesthesia. It is designed to treat patients with heart failure…”.

No tracked VC backing recorded
bioventrix.com ↗
Research BIOVENTRIX, INC.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Limited coverage
Homepage checked. Exit news coverage is not established.Homepage checked:

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Revivent Therapy is an investigational cardiac remodeling technique performed by a cardiothoracic surgeon under general anesthesia. It is designed to treat patients with heart failure…”.

Visit bioventrix.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $1,200,000 · Offering amount as filed: $3,000,000

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Leona Health

Limited coverage

Bio + Health

Company website description

Todos tus chats con pacientes de WhatsApp ahora en una sola app para que nunca pierdas un mensaje importante.

Andreessen Horowitz
leona.health ↗
Research Leona Health

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

Company website description

Todos tus chats con pacientes de WhatsApp ahora en una sola app para que nunca pierdas un mensaje importante.

Visit leona.health ↗Product description source ↗

Product source checked 1 Nov 2026

Source category

Bio + Health

Category source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Neon

Tracking

Product details not available yet.

Khosla Ventures
neon.tech ↗
Research Neon

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit neon.tech ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Pantheon

Tracking

Enterprise

RiseFinder summary

Pantheon provides a platform for building and managing websites.

First Round Capital
pantheon.io ↗
Research Pantheon

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

Pantheon provides a platform for building and managing websites.

Visit pantheon.io ↗
Source category

Enterprise

Category source ↗

Checked

Published location

SF Bay Area

Location source ↗

Checked

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Patreon

Tracking

Product details not available yet.

CRV
patreon.com ↗
Research Patreon

Tracking coverage

Some public sources are being tracked. Coverage varies by milestone.

Momentum +1 · Tracking
Comparable public measurements available. Points depend on your pick date.Last comparable reading:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

Product details not available yet.

Visit patreon.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Peca Labs, Inc.

Limited coverage

Other Health Care

On its website, the company describes its work as “Founded by a group of Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a…”.

No tracked VC backing recorded
pecalabs.com ↗
Research Peca Labs, Inc.

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Limited coverage
Verified filings recorded. Existing baseline history earns no points.SEC source checked:
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

What it does

On its website, the company describes its work as “Founded by a group of Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a…”.

Visit pecalabs.com ↗Product description source ↗

Tracked VC backing

No tracked VC backing recorded.

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

  • · Form D filing · Baseline

    Reported sold as filed: $12,789,342 · Offering amount as filed: $21,493,540

    SEC source checked 29 Oct 2026. Historical filing, not a current valuation.

    View original evidence ↗

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗

Vitara Biomedical

Limited coverage

RiseFinder summary

Vitara develops neonatal support technology for premature newborns.

Khosla Ventures
vitara.com ↗
Research Vitara Biomedical

Tracking coverage

Some source history is available; coverage remains limited.

Momentum +1 · Limited coverage
The latest public index does not report a rank for this company.Index checked:
Fundraising +2 · Awaiting data
No verified dated source evidence recorded.
New VC +3 · Awaiting data
No verified dated source evidence recorded.
Completed exit +10 · Awaiting data
Exit news coverage has not started.

Coverage describes public evidence. Points require a qualifying milestone after your pick.

RiseFinder summary

Vitara develops neonatal support technology for premature newborns.

Visit vitara.com ↗

Tracked VC backing

A portfolio listing documents backing; its observation date is not an investment date.

Dated public activity

No dated funding or investment events recorded yet.

History is research context. Only qualifying milestones after your pick earn points.

Company and sources ↗
How it works

Pick up to 50 companies. Your picks are private to your account.

A new US fundraising disclosure (Form D) earns 2 points. A first investment announced by a tracked VC earns 3. Milestones must occur and be observed after your pick.

Measured growth earns 1 point once: the same RiseFinder composite score rises between dated observations after your pick, using one formula version. Where available, a supported public source metric can also qualify. Lower ranks are better; rising counts are better. A completed, dated IPO or acquisition earns 10 points once.

The composite score measures relative public signals on a 0–100 scale. It is not a company valuation. Coverage varies; companies without qualifying history wait for evidence.

Initial imports, old discoveries, follow-ons from existing backers, amendments, undated events and same-day events earn no points.

Points track verified milestones after your pick. They do not represent investment returns.